Total Payments
$461,154
2024 Payments
$34,415
Companies
11
Transactions
414
Medicare Patients
2,518
Medicare Billing
$397,881
Payment Breakdown by Category
Other$401,310 (87.0%)
Travel$27,015 (5.9%)
Consulting$22,083 (4.8%)
Food & Beverage$10,569 (2.3%)
Education$177.28 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $401,310 | 163 | 87.0% |
| Travel and Lodging | $27,015 | 116 | 5.9% |
| Consulting Fee | $22,083 | 14 | 4.8% |
| Food and Beverage | $10,569 | 118 | 2.3% |
| Education | $177.28 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $272,243 | 194 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $104,672 | 122 | $0 (2020) |
| Astellas Pharma US Inc | $45,628 | 54 | $0 (2019) |
| Theravance Biopharma Inc. | $21,733 | 29 | $0 (2017) |
| ROCHE MOLECULAR SYSTEMS, INC. | $9,980 | 7 | $0 (2022) |
| Roche Diagnostics Corporation | $3,300 | 1 | $0 (2018) |
| Accelerate Diagnostics Inc. | $2,000 | 2 | $0 (2018) |
| Shionogi Inc | $800.00 | 1 | $0 (2020) |
| Paratek Pharmaceuticals, Inc. | $570.00 | 1 | $0 (2020) |
| AngioDynamics, Inc. | $129.58 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,415 | 24 | GlaxoSmithKline, LLC. ($34,415) |
| 2023 | $74,745 | 52 | GlaxoSmithKline, LLC. ($74,745) |
| 2022 | $111,964 | 80 | GlaxoSmithKline, LLC. ($108,643) |
| 2021 | $57,436 | 42 | GlaxoSmithKline, LLC. ($54,439) |
| 2020 | $4,642 | 4 | Merck Sharp & Dohme Corporation ($1,733) |
| 2019 | $29,206 | 37 | Merck Sharp & Dohme Corporation ($24,067) |
| 2018 | $59,547 | 65 | Merck Sharp & Dohme Corporation ($38,160) |
| 2017 | $89,199 | 110 | Merck Sharp & Dohme Corporation ($40,712) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $180.90 | General |
| Category: VACCINES | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $124.22 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $123.73 | General |
| Category: VACCINES | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $54.94 | General |
| Category: VACCINES | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: VACCINES | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $181.00 | General |
| Category: VACCINES | ||||||
| 05/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $121.18 | General |
| Category: VACCINES | ||||||
| 05/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $268.00 | General |
| Category: VACCINES | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: VACCINES | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $67.00 | General |
| Category: VACCINES | ||||||
| 05/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $207.70 | General |
| Category: VACCINES | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: VACCINES | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $110.44 | General |
| Category: VACCINES | ||||||
| 04/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: VACCINES | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Travel and Lodging | Cash or cash equivalent | $308.10 | General |
| Category: VACCINES | ||||||
| 01/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: VACCINES | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 579 | 1,256 | $199,135 | $92,943 |
| 2022 | 8 | 447 | 958 | $139,446 | $63,453 |
| 2021 | 7 | 670 | 1,778 | $228,879 | $110,328 |
| 2020 | 8 | 822 | 2,235 | $285,461 | $131,157 |
Total Patients
2,518
Total Services
6,227
Medicare Billing
$397,881
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 192 | 691 | $82,229 | $41,009 | 49.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 140 | 151 | $36,542 | $14,836 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 168 | $28,560 | $14,751 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 80 | $15,440 | $7,408 | 48.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 56 | $18,928 | $6,943 | 36.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 36 | 67 | $8,576 | $4,163 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,548 | $2,295 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 24 | $3,312 | $1,538 | 46.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 156 | 447 | $53,193 | $24,021 | 45.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 87 | 211 | $35,870 | $16,105 | 44.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 53 | 99 | $12,315 | $6,330 | 51.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 54 | 56 | $13,552 | $5,639 | 41.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $8,450 | $3,606 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 39 | $7,527 | $3,605 | 47.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 22 | 26 | $4,524 | $2,565 | 56.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 55 | $4,015 | $1,582 | 39.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 267 | 901 | $107,219 | $51,043 | 47.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 129 | 418 | $71,060 | $35,867 | 50.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 149 | 287 | $20,951 | $8,948 | 42.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 49 | $9,457 | $4,815 | 50.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 44 | 46 | $11,132 | $4,512 | 40.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 37 | 57 | $6,327 | $3,861 | 61.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 20 | $2,733 | $1,282 | 46.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 454 | 1,664 | $198,016 | $92,078 | 46.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 113 | 227 | $38,590 | $18,163 | 47.1% |
About Dr. Steven Burdette, MD
Dr. Steven Burdette, MD is a Infectious Disease healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760448518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Burdette, MD has received a total of $461,154 in payments from pharmaceutical and medical device companies, with $34,415 received in 2024. These payments were reported across 414 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($401,310).
As a Medicare-enrolled provider, Burdette has provided services to 2,518 Medicare beneficiaries, totaling 6,227 services with total Medicare billing of $397,881. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Dayton, OH
- Active Since 04/21/2006
- Last Updated 01/05/2016
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1760448518
Products in Payments
- SHINGRIX (Biological) $270,443
- ZERBAXA (Drug) $54,453
- Cresemba (Drug) $25,184
- VIBATIV (Drug) $21,733
- CRESEMBA (Drug) $19,943
- PNEUMOVAX 23 (Biological) $18,211
- SIVEXTRO (Drug) $14,438
- ZOSTAVAX (Biological) $10,002
- COBAS INSTRUMENTS & REAGENTS (Device) $3,662
- POC cobas Liat Analyzer, Assays, Controls and Accessories (Device) $3,300
- ACCELERATE PHENO (Device) $2,000
- BEXSERO (Biological) $1,800
- Fetroja (Drug) $800.00
- NUZYRA (Drug) $570.00
- Arikayce (Drug) $99.00
- DIFICID (Drug) $88.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Dayton
John Czachor, Md, MD
Infectious Disease — Payments: $59,863
Infectious Disease $59,863
Dr. Jeffrey Weinstein, Md, MD
Infectious Disease — Payments: $6,402
Infectious Disease $6,402
David Herman
Infectious Disease — Payments: $1,919
Infectious Disease $1,919
Dr. James Galbraith, Md, MD
Infectious Disease — Payments: $389.50
Infectious Disease $389.50
Dr. Jonathan Pope, M.d, M.D
Infectious Disease — Payments: $359.98
Infectious Disease $359.98
Dr. Richard Groger, Md, MD
Infectious Disease — Payments: $188.49
Infectious Disease $188.49